BiQadx
R&D Portfolio Overview · 25 Programs

Full Portfolio.

Browse the complete BiQadx R&D portfolio — instruments, cartridge systems, consumables, digital platforms, and technical documentation. All content is stage-tagged R&D. No clinical claims.

4
Instrument Platforms
8
Cartridge Systems
9
Consumable Lines
20+
Diagnostic Domains
Core Technology Stack

Built On Proven Disciplines.

Ten interlocking scientific disciplines form the technical foundation of every BiQadx platform. (R&D Stage)

Centrifugal Microfluidics

Siphon-valve disc geometry exploiting rotational frequency as the sole pumping mechanism — no active valves, no external pumps.

Acoustic Cell Separation

Standing 2 MHz acoustic fields stratify cells by compressibility contrast factor (Φ) — lysis-free, label-free, >97% purity target.

Lyophilised Reagents

Trehalose/sucrose glassy matrix (Tg >55°C) encapsulates enzymes and probes — >24-month ambient storage, <1% moisture by KF titration.

Optical Fluorometry

COP substrate fluorescence suppressed 8× vs PMMA at 488 nm excitation — enabling sub-picomolar detection without time-gating.

Edge AI Inference

INT8-quantised transformer on ARM Cortex-M7 interprets multi-channel fluorescence decay curves — <18 ms latency, zero cloud dependency.

FHIR / HL7 APIs

Bidirectional HL7 FHIR R4 integration for hospital LIS/LIMS, supporting real-time result push and patient record linkage (concept).

Electrochemical Biosensors

Screen-printed enzyme electrodes using DPV readout — sub-nanomolar sensitivity without optical components for metabolite panels.

ISO 14971 Risk Management

FMEA covering hardware, process, and software fault trees — risk register maintained from DHF initiation through each gate review.

Multiplex PCR / LAMP

Isothermal LAMP at 62°C achieves RT-PCR-equivalent sensitivity for 6 simultaneous respiratory targets in <45 min without thermocycling.

ISO 13485 QMS

Full Design History File (DHF) from concept stage — no retroactive documentation. Design controls enforced at every milestone gate.

Instrument Architecture · R&D Stage

Hardware Platforms.

Modular, scalable hardware from decentralised point-of-care to core-lab throughput. All content R&D stage tagged. No clinical claims.

R&DBQ-INST-POCT-001Instrument

Dr. POCT™

Modular Point-of-Care Analyzer

Modular point-of-care analyzer concept with cartridge families, dual-sensor optics, and an orchestration layer for decentralized diagnostics.

  • LIMS/AI orchestration hooks and traceability ID framework (concept)
  • Dual-sensor optical bench concept for multiplexed amplification curves
  • Embedded Wi-Fi 6 + BLE 5.2 for real-time hospital LIMS sync
Core Subsystems

Optical Bench (Concept)

Multi-channel fluorescence sensing array concept for multiplexed amplification curves.

Thermal Block (Concept)

Peltier-driven active heating/cooling concept with fast ramp rate planning.

Microfluidic Actuator (Concept)

Precision stepper motor concept for valving and pneumatic blister actuation.

Edge Connectivity (Concept)

Embedded Wi-Fi 6 + BLE 5.2 concept for hospital network and LIMS sync.

R&D-stage content only. No clinical claims. No performance guarantees.

Catalogue Specification

Catalogue IDBQ-INST-POCT-001
StageR&D
Platform classDecentralized / Point-of-Care
Primary carrierPOCT cartridge families (concept)
Connectivity conceptWi-Fi 6 + BLE 5.2 + LIMS API
Versioningv2.1.0-alpha (R&D internal)
01 / 04
Development Timeline

Program Overview.

A disciplined, milestone-gated progression from architecture lock through IVDR-aligned market readiness — each phase requiring a signed evidence package before promotion.

2022 – 2023
Phase 01
Architecture Lock

Core system architecture defined for HELIX ONE instrument family. Requirements traceability matrix established. CAD models for centrifugal disc geometry finalized. Risk register and FMEA initiated across all three engineering domains.

Gate Criteria

Gate criteria: Design input freeze, risk classification (Class IIa IVD) assigned per IVDR 2017/746, DHF structure approved by QA.

  • Requirements Traceability Matrix v1.0
  • FMEA draft — hardware, chemistry, software
  • Centrifugal disc CAD geometry v2.1
Active
2023 – 2024
Phase 02
R&D Parallel Tracks

Simultaneous development across hardware mechanics, assay chemistry, and LIMS/AI software architecture. Four hardware platforms initiated from DHF baseline. Lyophilisation formulation screening commenced across 5 matrix variants.

Gate Criteria

Gate criteria: Platform concept feasibility reviews signed. TRL 3 bench evidence documented for each discipline.

  • Platform architecture briefs (4× instruments)
  • Lyophilisation screening report — DSC Tg data
  • LIMS AI architecture design v0.5
2024 – 2025
Phase 03
Prototype Integration

Alpha hardware units assembled for bench-level integration testing. IQ/OQ protocol drafting begins. Assay chemistry enters microfluidic compatibility validation. Acoustic separation module bench characterization for PZT-5A resonant frequency matching.

Gate Criteria

Gate criteria: IQ/OQ protocols approved. Alpha unit bench performance meets TRL 4 evidence package criteria.

  • Alpha instrument units (IQ/OQ tested)
  • Assay-microfluidic compatibility report
  • Acoustic separation bench characterization
2025 – 2026
Phase 04
Controlled Pilot

Controlled external site deployment at partner institutions under strict site management plan. Operator training and Human Factors Engineering evaluation. CAPA system activated. Prospective data collection for validation report.

Gate Criteria

Gate criteria: Site Management Plan approved. ≥200 samples collected per assay panel. CAPA closure rate ≥90%.

  • Site Management Plan + training materials
  • Human Factors Engineering study report
  • Prospective validation dataset (pilot)
2026+
Phase 05
Market Readiness

Regulatory submission strategy initiated under ISO 13485 QMS. Technical File compilation for IVDR CE-IVD. Commercial production planning and supply chain qualification. International distribution architecture across three geographies defined.

Gate Criteria

Gate criteria: Technical File approved by Notified Body. QMS certified to ISO 13485. Commercial launch plan signed off.

  • IVDR Technical File (CE-IVD pathway)
  • Commercial production + supply chain plan
  • Distribution architecture (3 geographies)
Phase 01
Phase 02
Phase 03
Phase 04
Phase 05
Complete R&D Portfolio

25 Active Programs.

BQ-SYS-POCT-001

Dr. POCT

Prototype
BQ-SYS-POCT-001

Compact immunoassay platform designed for decentralized environments, bringing lab-grade precision to the point of care.

R&D Stage
BQ-SYS-ETHX-001

EtherX-1

R&D
BQ-SYS-ETHX-001

High-throughput modular system engineered for core laboratories with advanced microfluidic handling.

R&D Stage
BQ-SYS-VGAS-001

Vital+Gas Console

Pilot
BQ-SYS-VGAS-001

Advanced blood gas and electrolyte analyzer designed for critical care environments.

R&D Stage
BQ-SYS-HEMO-002

HemoCount XR

Planned
BQ-SYS-HEMO-002

Next-generation complete blood count (CBC) analyzer leveraging AI-driven optical cytometry for precise cell differentiation.

R&D Stage
BQ-SYS-MOLEX-001

OmniSense PCR

Concept
BQ-SYS-MOLEX-001

Rapid, multiplexed molecular diagnostic platform aimed at syndromic panel testing at the point of need.

R&D Stage
BQ-SYS-PATH-001

TissueScanner Pro

R&D
BQ-SYS-PATH-001

High-resolution digital pathology slide scanner designed to integrate seamlessly into LIMS for remote AI analysis.

R&D Stage
BQ-SYS-HLX-001

HELIX ONE

R&D
BQ-SYS-HLX-001

Integrated molecular diagnostic and immunology system designed for mid-volume hospital laboratories.

R&D Stage
BQ-SYS-ECO-001

EcoBio Labware

Concept
BQ-SYS-ECO-001

Next-generation biodegradable diagnostic consumables and labware crafted from plant-derived biopolymers — engineered for zero-waste, high-precision diagnostic workflows.

R&D Stage
BQ-CAR-STC-001

Standard Test Cartridge (STC)

Prototype
BQ-CAR-STC-001

Microfluidic cassette engineered for rapid near-patient immunoassay testing. Features integrated lyophilized reagents for cardiac markers.

R&D Stage
BQ-CAR-STC-002

Sepsis Alert Cartridge (SAC)

R&D
BQ-CAR-STC-002

Advanced multiplex cartridge combining PCT (Procalcitonin) and IL-6 within a 15-minute timeframe for critical care screening.

R&D Stage
BQ-DISC-ETHX-001

EtherX CMP Disc

R&D
BQ-DISC-ETHX-001

Centrifugal microfluidic disc architecture allowing simultaneous processing of 14 key metabolic assays per run.

R&D Stage
BQ-DISC-ETHX-002

EtherX Lipid Profile Disc

Concept
BQ-DISC-ETHX-002

High-throughput centrifugal disc dedicated to complete lipid fractionation and cardiovascular risk assessment.

R&D Stage
BQ-CAR-VGAS-100

Vital+Gas Sensor Array

Pilot
BQ-CAR-VGAS-100

Thick-film multi-sensor array cartridge capable of executing 10 critical parameters from a single 80µL arterial blood drop.

R&D Stage
BQ-CAR-MOL-200

OmniSense Respiratory Panel

Concept
BQ-CAR-MOL-200

Fully self-contained qRT-PCR cartridge utilizing dried down primer/probe mixes for differentiating up to 8 respiratory pathogens.

R&D Stage
BQ-CAR-AST-100

Microbiology AST-ID Panel

Concept
BQ-CAR-AST-100

Rapid antimicrobial susceptibility testing and identification mapping cartridge.

R&D Stage
BQ-MAG-ETHX-001

EtherX Reagent Magazine

R&D
BQ-MAG-ETHX-001

Multi-chamber reagent delivery module for automated loading into the EtherX system.

R&D Stage
BQ-LAB-TUBE-001

Capillary Collection Tube (LH)

Pilot
BQ-LAB-TUBE-001

100µL capillary tube pre-coated with Lithium Heparin. Designed for the Dr. POCT interface.

R&D Stage
BQ-LAB-TUBE-002

Serum Separation Tube (SST / Gel)

Prototype
BQ-LAB-TUBE-002

5mL evacuated tube with inert polymer gel for pristine serum extraction, optimized for EtherX robotic handling.

R&D Stage
BQ-LAB-TIPS-001

Precision Tips 200µL Filtered

Planned
BQ-LAB-TIPS-001

Premium sterile filtered tips engineered for liquid handlers to prevent aerosol contamination.

R&D Stage
BQ-LAB-TIPS-002

Robotic Grip Tips 1000µL

Concept
BQ-LAB-TIPS-002

High-volume tips with reinforced mounting collars for high-speed Z-axis gantry acceleration.

R&D Stage
BQ-LAB-SYR-001

Arterial Blood Gas Syringe 3mL

Pilot
BQ-LAB-SYR-001

Dry-lithium heparinized syringe with vented plunger specifically calibrated for the Vital+Gas Console intake port.

R&D Stage
BQ-LAB-SLIDE-001

OptiClear Pathology Slides

R&D
BQ-LAB-SLIDE-001

Ultra-flat borosilicate glass with proprietary hydrophilic coating to minimize tissue folding before TissueScanner operation.

R&D Stage
BQ-LAB-MAG-001

Magnetic Bead Extraction Array

Concept
BQ-LAB-MAG-001

96-well format deep plate pre-loaded with silica-coated superparamagnetic beads for nucleic acid extraction.

R&D Stage
BQ-PPE-GOWN-001

Eco-PPE Isolation Gown

Concept
BQ-PPE-GOWN-001

Bio-polymer concept isolation gown designed to minimize petroleum-based waste in high-turnover clinical settings.

R&D Stage
BQ-PPE-MASK-001

Eco-PPE Procedural Mask

Concept
BQ-PPE-MASK-001

Breathable, high-filtration mask utilizing compostable microfiber layers. Exploration prototype.

R&D Stage
Configure Architecture

Build Together.

Use the AI Agent to explore hardware combinations, carrier mappings, and LIMS integration concepts. Or open an RFQ for R&D collaboration discussion.

R&D information only · No clinical claims · No medical advice

BiQadx content is R&D / prototype / pilot-stage. No clinical claims. For planning and technical understanding only. Not medical advice.